A study by Zhu X. et al. in 2016 [31] showed, both in vitro and in vivo, that TB has anti-osteoclastogenic activity by blocking the RANKL-induced activation of the MAPK-signaling pathways (ERK, JNK and p38). The gene discussed is MAPK8; the disease is tuberculosis.